Integra LifeSciences Schedules Conference Call for Thursday, July 31 to Discuss Second Quarter 2003 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J.-July 22, 2003-- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced that it has scheduled a conference call for 9:00 AM EST on Thursday, July 31 to discuss financial results for the second quarter ended June 30, 2003 and to update forward-looking financial guidance. Financial results for the second quarter 2003 will be announced via a news release issued before the market opens on July 31.
The upcoming conference call, which will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, is open to all listeners and will be followed by a question and answer session. Additional forward-looking information may be discussed in the question and answer session following the call.
Access to the live call is available by dialing 973-935-2100 or through a listen-only webcast via a link provided on the home page of Integra's website at www.Integra-LS.com. A replay of the conference call will be accessible starting one hour following the live event. Access to the replay is available through August 14 by dialing 973-341-3080 (PIN code 3609052) or through the webcast accessible on our home page.
Mr. Essig's presentation will provide an overview of the Company's business, a review of recent financial history, including financial results from the second quarter ended June 30, 2003, and the Company's overall business strategy.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for our products are neuro-trauma and neurosurgery, plastic and reconstructive surgery, and soft tissue repair. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. The Company has its corporate headquarters in Plainsboro, New Jersey, with manufacturing and research facilities located throughout the world. The Company has approximately 860 permanent employees. Please visit the Company's Website at (http://www.Integra-LS.com).
Statements made in the upcoming conference call may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted results. Forward-looking factors that may be discussed include, but are not limited to, expected future financial results, new product development, governmental approvals, market potential, expected sales and potential therapeutic applications of new products, and additional business acquisitions. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in the Business section of Integra's Annual Report on Form 10-K for the year ended December 31, 2002 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
Source: Integra LifeSciences Holdings Corporation
Contact:
Integra LifeSciences Holdings Corporation
John Bostjancic
Senior Director of Finance
(609) 936-2239
jbostjancic@integra-ls.com